9. Pactiv Evergreen will "combine" with Novolex, the Charlotte-based company that bought the company in an all-cash transaction valued at $6.7 billion, the Dec. 9 news release announced.

https://www.tipranks.com/news/the-fly/general-motors-price-target-lowered-to-35-from-38-at-wells-fargo Baird analyst Ghansham Panjabi raised the firm’s price target ...

Citi downgraded Pactiv Evergreen (PTVE) to Neutral from Buy with a price target of $18, up from $13. The firm sees limited upside to the shares following the announced combination with Novolex.